Best King County Grants for Nonprofits in Washington

The WA New & Recompete AmeriCorps Operational Grant supports organizations ready to launch or renew AmeriCorps programs, enhancing national service and community engagement in Washington. This funding is ideal for new applicants or those completing a three-year grant cycle. It focuses on impactful service areas such as disaster relief, education, and economic opportunity, aiming to strengthen community resilience and address local needs effectively.

The AAD Advocate Of The Year Award, presented by the American Academy of Dermatology Association, honors exceptional grassroots advocacy efforts in dermatology. This prestigious award promotes year-round advocacy and highlights the significant impact of dedicated individuals. Eligibility includes active participation in legislative efforts and direct engagement with legislators. It aims to inspire and recognize those who contribute to the advancement of dermatology and skin health through advocacy initiatives.

The Patient-Centered Outcomes Research Institute (PCORI) will announce funding for patient-centered comparative clinical effectiveness research (CER) studies focusing on rare diseases. This initiative encourages collaboration and aims to fill critical research gaps affecting approximately 30 million Americans with rare diseases. Applications can request up to $12 million over five years, including coverage for patient care costs. This funding opportunity is set to open on August 12, 2025, with a focus on addressing pressing patient-centered CER questions.

The PCORI Engagement Award: Capacity Building aims to enhance the capacity of patients and stakeholders in patient-centered comparative clinical effectiveness research (CER). Projects can last up to two years with funding up to $300,000. Successful proposals will demonstrate understanding of CER, community engagement, and commitment from stakeholders. The initiative encourages the use of existing tools and resources to foster patient involvement in research processes, aligning with national health priorities and addressing pressing healthcare issues.

The Engagement Award: Dissemination Initiative, part of the Eugene Washington PCORI program, focuses on promoting active involvement of patients, families, and caregivers in health research. It supports organizations in effectively communicating PCORI-funded research findings to their audiences, enhancing understanding and application in healthcare decisions. Projects must demonstrate stakeholder engagement and a solid evaluation plan. This initiative aims to bridge the gap between research and community application, ensuring impactful dissemination of critical health information.

The Craft Archive Fellowship supports archival research on underrepresented craft histories in the U.S., including feminist, queer, Black, Indigenous, and other marginalized communities. It offers a $5,000 stipend for scholars and artists to conduct research in chosen archives, encouraging innovative approaches. Participants will present their findings in a virtual program, and their work will be published in Hyperallergic, broadening accessibility and awareness of vital craft research.

The Kuni Foundation's Imagination Planning Grant focuses on addressing the urgent need for quality, affordable housing for individuals with intellectual and developmental disabilities (IDD) in Oregon and Washington. With funding ranging from $15,000 to $75,000, the grant supports organizations dedicated to developing inclusive housing solutions. Eligible applicants include 501(c)(3) non-profits committed to serving the IDD community, ensuring that innovative and sustainable housing options are explored and implemented.

The CAA Professional Development Fellowship in Art History provides crucial support for recent PhD graduates and scholars from multicultural and underrepresented backgrounds in the field of art history. This fellowship awards $10,000 to assist with job-search expenses, image licensing, and publishing costs. Additionally, each recipient gains a one-year CAA membership and free registration for the upcoming Annual Conference, encouraging diverse voices in the art community to flourish.

The CAA Professional Development Fellowship in Visual Arts offers a $10,000 grant to support MFA students and artists from underrepresented groups. This fellowship aids in job-search expenses or purchasing materials for their studio practice. Recipients also receive a one-year CAA membership and free registration to the Annual Conference. Honorable Mentions will also receive membership and conference registration. This initiative promotes diversity and provides crucial support to emerging artists in their professional journey.

The NIDCD Mentored Career Development Award for Postdoctorate Au.D./Ph.D. Audiologists (K01) aims to foster the development of promising audiologists through comprehensive postdoctoral research experiences. This funding opportunity supports individuals in biomedical, behavioral, or clinical sciences, helping them become independent researchers. The deadlines for applications span from June 2024 to May 2027, ensuring ample time for preparation and submission.

The NIDCD Mentored Career Development Award supports postdoctoral Au.D./Ph.D. audiologists in their research and career development. This grant aims to foster independence in scientific health-related research relevant to the NIDCD's mission. Key deadlines for applications span from June 2024 to May 2027, providing numerous opportunities for eligible candidates to secure funding and advance their careers in the biomedical and clinical sciences.

The NIDCD Mentored Career Development Award for Postdoctorate Au.D./Ph.D. Audiologists (K01) aims to support the career development of promising audiologists through rigorous postdoctoral research in biomedical, behavioral, or clinical sciences. This initiative encourages independent investigation in health-related research relevant to NIDCD's mission. Applications are due on various dates, with the next deadline on June 13, 2024, providing opportunities for advancing research in audiology and related fields.

The New Foundation for Art History (NFAH) offers innovative non-residential fellowships for mid-career scholars, emphasizing excellence in research across various art eras and cultures. Established in 2019, NFAH aims to support scholars from U.S. institutions, particularly those at smaller schools, with grants up to $50,000 to aid in their research endeavors. The initiative promotes diversity and equity within the field, ensuring that scholars receive the resources they need to thrive.

The New Foundation for Art History (NFAH) offers Fellowships for Contingent Faculty to address the growing reliance on contingent positions in art history. Launched in 2019, these fellowships provide $10,000 to $15,000 for each summer, up to $45,000 over three years. By accommodating the unique schedules of contingent faculty, NFAH aims to support research and publication efforts, facilitating career advancement and promoting equity within the discipline.

The New Foundation for Art History (NFAH), established in 2019, aims to innovate within the art history field by addressing gaps left by other institutions. Offering five publication subvention grants of $1,000 to $5,000, NFAH prioritizes applications from U.S. scholars, especially those in underrepresented areas. With a commitment to diversity and equity, NFAH adapts its initiatives based on community feedback, fostering excellence in research and publication.

The ARRL Foundation offers grants for amateur radio projects, focusing on education, licensing, and community support in the U.S. Organizations can apply three times a year for funding, with a preference for youth initiatives and sustainable projects. Notably, grants are awarded exclusively to organizations, not individuals, and emergency communication equipment requests are ineligible. This funding aims to enhance amateur radio's public service and technological advocacy.

Myasthenia Gravis Rare Disease Network (MGNet)

The Myasthenia Gravis Rare Disease Network (MGNet) is a consortium of academic medical centers partnering with the Myasthenia Gravis Foundation of America and Conquer MG as well as collaborators in other research groups and industry. We are working together to enhance therapeutic development for this rare disease.

Diseases Studied

Myasthenia Gravis (MG) and its subtypes:

• Early-onset acetylcholine receptor (AChR) antibody (Ab) positive MG, which primarily affects women
• Late-onset AChR Ab positive MG with a disease bias towards men
• Paraneoplastic thymoma-associated MG
• Muscle specific kinase (MuSK) Ab positive
• AChR/MuSK antibody negative MG

Goals, Mission, & Vision

The goal of MGNet is to advance therapeutic development. To do so we have four specific aims:

• Improve the tools scientists and doctors have for performing clinical trials through rigorous monitoring of patients over time and evaluate better measures of how patients are doing.
• Identify objective measures (biomarkers) to show how the disease is responding to treatment and better predict treatment response or side effects, to improve the design of clinical trials and care of patients in clinical practice.
• Enhance the education of young investigators focusing their careers on rare diseases and specifically MG.
• Improve the awareness of scientists, physicians, and the public regarding the unique needs of patients with MG through training of clinician scientists and engagement of the patient and scientific communities in clinical research and therapeutic development.

Scholar Awards

Objectives

There is a critical need for investigators prepared to conduct clinical and translational research in myasthenia gravis (MG). The MGNet Scholar Program provides individualized training and mentorship in one of two tracks, Clinical Research or Biomarker Development Research.

Award Description

The MGNet Scholar Program provides mentored research training to prepare Scholars for an independent research career in the field of MG. The MGNet Scholar Program is 1 year in duration and selected Scholars receive up to $100,000 to support salary, research costs and didactics with potential for renewal. The program will provide an additional $3,000 to travel to MGNet sites to learn specific skills and/or to scientific meeting(s) to present the results of their research. If available for renewal, the program requires approval after interim report and is contingent on demonstration of adequate progress on the research and career development plan. Indirect costs are not allowed. Scholars are encouraged to transition to NIH (e.g., K award), departmental, or private foundation support for their research and further career development.Research must constitute at least 50% of each Scholar’s professional effort. Each Scholar must form a 2-3-member advisory committee to include a primary mentor, an additional clinician investigator or collaborator, and a MGNet faculty sponsor. The advisory committee will meet with the Scholar at least quarterly to review progress and each Scholar will develop an individual academic career development plan and renew it with the committee at least every 6 months.

The Michael Aurbach Fellowship for Excellence in Visual Art, awarded by the College Art Association, supports artist members with an MFA or equivalent who teach studio classes. This fellowship provides a $7,500 award and conference registration to a qualifying artist, focusing on their artistic work rather than a proposal. It aims to recognize and empower visual arts professionals in academia.

Myasthenia Gravis Rare Disease Network (MGNet)

The Myasthenia Gravis Rare Disease Network (MGNet) is a consortium of academic medical centers partnering with the Myasthenia Gravis Foundation of America and Conquer MG as well as collaborators in other research groups and industry. We are working together to enhance therapeutic development for this rare disease.

Diseases Studied

Myasthenia Gravis (MG) and its subtypes:

• Early-onset acetylcholine receptor (AChR) antibody (Ab) positive MG, which primarily affects women
• Late-onset AChR Ab positive MG with a disease bias towards men
• Paraneoplastic thymoma-associated MG
• Muscle specific kinase (MuSK) Ab positive
• AChR/MuSK antibody negative MG

Goals, Mission, & Vision

The goal of MGNet is to advance therapeutic development. To do so we have four specific aims:

• Improve the tools scientists and doctors have for performing clinical trials through rigorous monitoring of patients over time and evaluate better measures of how patients are doing.
• Identify objective measures (biomarkers) to show how the disease is responding to treatment and better predict treatment response or side effects, to improve the design of clinical trials and care of patients in clinical practice.
• Enhance the education of young investigators focusing their careers on rare diseases and specifically MG.
• Improve the awareness of scientists, physicians, and the public regarding the unique needs of patients with MG through training of clinician scientists and engagement of the patient and scientific communities in clinical research and therapeutic development.

Pilot and Feasibility Grants

Objectives

MGNet, a NIH-funded Rare Diseases Clinical Research Consortium (RDCRC) in partnership with the Myasthenia Gravis Foundation of America and Conquer MG, is seeking proposals for highly innovative investigations in early stages of development.

The priorities of the Pilot Grant Program are:

• Identification treatment responsive biomarkers
• Assess clinical measures and improve that enhance clinical trial readiness
• Evaluation of therapeutic interventions for one or more of the five distinct sub-types of MG

Pilot studies must be designed to access the resources of MGNet and focused on clinical and translational research, including fulfilling the definition of clinical and translational research and exclusion of animal studies.

Funding

The MGNet expects to fund up to two grants, each at a level of $75,000 (IDCs will be limited to 10% and included in the $75,000). Projects will be funded for 12 months. Selection among the applications received will be based on the recommendations of a review committee. A grant may be renewed for an additional one year with approval of interim report by the same review process and availability of funds. Demonstration of fulfillment of initial aims and justification for additional funding will be required. The request will be required a minimum of three months prior to the initial funding period completion.

The NewSchools: Teaching Reimagined Grant offers a unique funding opportunity of $150,000 to $250,000 for innovative ideas aimed at reimagining the role of educators and enhancing student outcomes. With a focus on leveraging generative AI, the grant supports early-stage organizations and initiatives that prioritize diverse teaching strategies and community involvement. The application deadline is January 8, 2026, with a priority deadline of December 1, 2025, for updates on eligibility.

The Development Advocacy Grant by AADA supports state dermatology societies new to advocacy, providing essential funding for health policy initiatives and lobbying. This program is tailored for states with limited prior funding, ensuring a simplified application process to encourage participation. Eligible states must align their projects with AADA's policy priorities and submit a final report detailing advocacy progress. This initiative fosters growth in advocacy efforts, empowering societies to influence key legislation effectively.

The FWW Fellowship Award supports emerging physicians and scientists dedicated to advancing women’s health research. Awardees, pursuing MD or PhD programs at U.S. institutions, explore critical health topics such as cardiovascular disease, leading female cancers, and the role of hormones. This initiative encourages diverse applicants and promotes innovative proposals that address health concerns disproportionately affecting women. With a commitment to fostering research excellence, the FWW Fellowship Award empowers the next generation of health leaders.

The FWW Research Awards support short-term studies focused on critical women’s health issues such as cardiovascular disease, female cancers, and hormonal influences on health. Eligible applicants include MDs or PhDs affiliated with accredited institutions. Research proposals must align with FWW's priority areas, and financial support must be confirmed to ensure project completion. Note that sociological studies are not funded, and only one application per Principal Investigator is allowed.

This program aims to enhance education for healthcare professionals regarding new therapies and patient management in ulcerative colitis (UC). It focuses on multi-channel educational strategies to address the evolving landscape of UC treatment. Key areas include educating on new oral therapies, transitioning to advanced therapies, and managing isolated proctitis. Organizations such as healthcare institutions and medical education companies are eligible to apply, ensuring a comprehensive approach to improving UC care.

The T.E.A.L. Research Grant supports innovative ovarian cancer research initiatives aligned with the mission of the Tell Every Amazing Lady About Ovarian Cancer Foundation. Designed for researchers affiliated with 501(c)3 not-for-profit institutions in the U.S., the grant aims to enhance women's health awareness and education regarding ovarian cancer. While the application period for 2025 is currently closed, interested parties should anticipate further updates in spring 2026.

The Technologies for Improving Minority Health and Eliminating Health Disparities (R41/R42) program invites small business concerns to develop innovative technologies aimed at enhancing minority health and addressing health disparities. This initiative emphasizes the creation of effective, affordable, and culturally acceptable solutions for NIH-defined populations. Key deadlines for applications span from June 2024 to December 2026, with optional Letters of Intent encouraged 30 days prior to submission.

The Innovations for Healthy Living program invites eligible U.S. small businesses to apply for SBIR grants aimed at improving minority health and eliminating health disparities. The initiative encourages innovative proposals for effective, affordable, and culturally acceptable solutions. Key deadlines for applications span from June 2024 to December 2026, with optional Letters of Intent recommended 30 days prior to submission. This funding opportunity supports projects that address health challenges faced by underserved populations.